LifeStance Health GroupLFST +2.22%57 PS Ratio is 2.55 as of Jun. 24, 2026, which is 9% above its 10-year median of 2.33. GuruFocus rates LFST with a GF Score™ of 57/100 and a GF Value™ of $8.22 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 663 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 65.91% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, LifeStance Health Group's share price is $9.65.
LifeStance Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $3.79. Hence, LifeStance Health Group's PS Ratio for today is 2.55.
Warning Sign:
LifeStance Health Group Inc stock PS Ratio (=2.49) is close to 2-year high of 2.49.
The historical rank and industry rank for LifeStance Health Group's PS Ratio or its related term are showing as below:
LFST'
s PS Ratio Range Over the Past 10 Years
Min: 1.11 Med: 2.33 Max: 25.69
Current: 2.51
During the past 7 years, LifeStance Health Group's highest PS Ratio was 25.69. The lowest was 1.11. And the median was 2.33.
LFST's PS Ratio is ranked worse than 65.91% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs LFST: 2.51
During the past 7 years, LifeStance Health Group's highest 3-Year average Revenue per Share Growth Rate was 62.00% per year. The lowest was 14.60% per year. And the median was 17.40% per year.
Back to Basics: PS Ratio
LifeStance Health Group (NAS:LFST) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LifeStance Health Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
LifeStance Health Group's Share Price of today is $9.65. LifeStance Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.79.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
LifeStance Health Group (LFST) has a PS Ratio of 2.55 as of Jun. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on LifeStance Health Group and its competitors. This is near median its historical median of 2.33. Over the past decade, LifeStance Health Group's PS Ratio has ranged from 1.11 to 25.69. According to the industry distribution chart, LifeStance Health Group ranks #437 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 65.9%.
Is LifeStance Health Group's PS Ratio too high?
LifeStance Health Group's current PS Ratio of 2.55 is near median its 10-year median of 2.33. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 25.69. The Healthcare Providers & Services industry median PS Ratio is 1.47. LifeStance Health Group's value of 2.55 is 73.5% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #437 out of 663 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's PS Ratio compare to NHC and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #437 out of 663 companies for PS Ratio. This places LifeStance Health Group in the lower half of its industry. The industry median PS Ratio is 1.47. LifeStance Health Group's value of 2.55 is 73.5% above this benchmark. Historically, LifeStance Health Group's own PS Ratio has ranged from 1.11 to 25.69 over the past decade. While the company's 10-year median is 2.33 vs. the industry median of 1.47, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current PS Ratio of 2.55 is 73.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current PS Ratio is 2.55, which is near median its own 10-year median of 2.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.22, compared to a current price of $9.65 — trading 17.4% above its estimated fair value. The current PS Ratio is 2.55, which is near median its 10-year median of 2.33 and 73.5% above the Healthcare Providers & Services industry median of 1.47. LifeStance Health Group's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current PS Ratio is 2.55 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $9.65 is trading 17.4% above its estimated GF Value™ of $8.22.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
PS Ratio: 2.55 (near median its 10-year median of 2.33)
GF Value™: $8.22 vs. price of $9.65 (17.4% above fair value)
Industry Position: 73.5% above the Healthcare Providers & Services median (#437 of 663)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
57GF Score
Get the complete analysis for LFST
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
